<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Medicis Pharmaceutical Corporation</title>
    <link>http://www.newstin.com/us/MEDICIS_PHARMACEUTICAL_CORPORATION</link>
    <description>Global Social News Platform</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Medicis notifies SEC of patent inquiry</title>
      <link>http://www.newstin.com/tag/us/75296185</link>
      <description>Scottsdale-based Medicis Pharmaceutical Corporation filed notice Thursday with the U.S. Securities and Exchange Commission that the U.S. Patent and Trademark Office is re-examining its patent for the acne treatment Solodyn.</description>
      <pubDate>Fri, 22 Aug 2008 01:26:27 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/75296185</guid>
      <dc:date>2008-08-22T01:26:27Z</dc:date>
    </item>
    <item>
      <title>Medicis Pharmaceutical Corporation Q2 2008 Earnings Call Transcript (at Seeking Alpha)</title>
      <link>http://www.newstin.com/tag/us/74704113</link>
      <description>posted on: August 19, 2008 | about stocks: MRX Q2 2008 Earnings Call Transcript Executives Jonah Shacknai – Chairman and CEO Mark Prygocki – EVP and COO Rick Peterson – CFO, EVP and Treasurer Joe Cooper – EVP of Corporate and...</description>
      <pubDate>Tue, 19 Aug 2008 06:52:37 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74704113</guid>
      <dc:date>2008-08-19T06:52:37Z</dc:date>
    </item>
    <item>
      <title>Second Quarter 2008 Medicis Earnings Call scheduled for Tue, Aug 5 (CCBN)</title>
      <link>http://www.newstin.com/tag/us/71643149</link>
      <description>Second Quarter 2008 Medicis Earnings Conference Call Scheduled to start Tue, Aug 5, 2008, 5:15 pm Eastern After the event has finished, the audio will be available from this page until Thu, Aug 6, 2009 Medicis Pharmaceutical...</description>
      <pubDate>Fri, 01 Aug 2008 02:28:43 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/71643149</guid>
      <dc:date>2008-08-01T02:28:43Z</dc:date>
    </item>
    <item>
      <title>Medicis Announces Second Quarter 2008 Conference Call and Webcast</title>
      <link>http://www.newstin.com/tag/us/71553727</link>
      <description>SCOTTSDALE, Ariz., July 31, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2008 second quarter financial results after the market closes on Tuesday, August 5, 2008. Medicis will host a...</description>
      <pubDate>Thu, 31 Jul 2008 14:01:26 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/71553727</guid>
      <dc:date>2008-07-31T14:01:26Z</dc:date>
    </item>
    <item>
      <title>MEDICIS PHARMACEUTICAL CORP Files SEC form 8-K, Completion of Acquisition or Disposition of...</title>
      <link>http://www.newstin.com/tag/us/66344115</link>
      <description>| Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICIS PHARMACEUTICAL CORP Completion of Acquisition or Disposition of Assets Item 2.01. As previously reported, on June 16, 2008, Medicis Pharmaceutical Corporation...</description>
      <pubDate>Thu, 03 Jul 2008 20:31:40 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66344115</guid>
      <dc:date>2008-07-03T20:31:40Z</dc:date>
    </item>
    <item>
      <title>Female investing group learns from surroundings</title>
      <link>http://www.newstin.com/tag/us/65268831</link>
      <description>By Roseann Keegan • Special to • June 28, 2008 Sometimes smart investing comes down to paying attention to the world around you. For the eight members of the all-women Let it Ride Investors Club of Carson Valley, paying...</description>
      <pubDate>Sat, 28 Jun 2008 09:01:31 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/65268831</guid>
      <dc:date>2008-06-28T09:01:31Z</dc:date>
    </item>
    <item>
      <title>MEDICIS PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR...</title>
      <link>http://www.newstin.com/tag/us/63591770</link>
      <description>| Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICIS PHARMACEUTICAL CORP Entry into a Material Definitive Agreement Item 1.01. On June 16, 2008, Medicis Pharmaceutical Corporation ("Medicis") entered into a definitive...</description>
      <pubDate>Thu, 19 Jun 2008 15:37:53 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/63591770</guid>
      <dc:date>2008-06-19T15:37:53Z</dc:date>
    </item>
    <item>
      <title>Medicis To Acquire LipoSonix</title>
      <link>http://www.newstin.com/tag/us/63205565</link>
      <description>Medicis and LipoSonix, Inc. jointly announced they have entered into a definitive merger agreement under which Medicis will acquire LipoSonix, an independent, privately-held company with a staff of approximately 40 scientists,...</description>
      <pubDate>Tue, 17 Jun 2008 23:07:08 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/63205565</guid>
      <dc:date>2008-06-17T23:07:08Z</dc:date>
    </item>
    <item>
      <title>Medicis Declares Cash Dividend</title>
      <link>http://www.newstin.com/tag/us/61989204</link>
      <description>SCOTTSDALE, Ariz., June 11, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.04 per issued and outstanding share of its Common Stock payable on...</description>
      <pubDate>Wed, 11 Jun 2008 14:01:09 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/61989204</guid>
      <dc:date>2008-06-11T14:01:09Z</dc:date>
    </item>
    <item>
      <title>Perrigo Confirms Filing for Generic Version of VANOS(R) (PR Newswire)</title>
      <link>http://www.newstin.com/tag/us/61911109</link>
      <description>Perrigo Company today announced that it has filed an Abbreviated New Drug Application for Fluocinonide Cream 0.1%, a generic version of VANOS® Cream 0.1%. The Company believes that it is the first to file an ANDA with a...</description>
      <pubDate>Wed, 11 Jun 2008 10:36:49 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/61911109</guid>
      <dc:date>2008-06-11T10:36:49Z</dc:date>
    </item>
  </channel>
</rss>

